Medicare Part D: a first look at prescription drug plans in 2018

Medicare Part D: a first look at prescription drug plans in 2018

Collection:
Health Policy and Services Research
Series Title(s):
Issue brief (Henry J. Kaiser Family Foundation)
Author(s):
Cubanski, Juliette, author
Damico, Anthony, author
Hoadley, Jack, author
Orgera, Kendal, author
Neuman, Tricia, author
Contributor(s):
Henry J. Kaiser Family Foundation, issuing body.
Publication:
Menlo Park, CA : Henry J. Kaiser Family Foundation, October 2017
Language(s):
English
Format:
Text
Subject(s):
Medicare Part C -- economics
Medicare Part C -- statistics & numerical data
Medicare Part C -- trends
Medicare Part D -- economics
Medicare Part D -- statistics & numerical data
Medicare Part D -- trends
United States
Genre(s):
Technical Report
Abstract:
During the Medicare open enrollment period from October 15 to December 7 each year, beneficiaries can enroll in a plan that provides Part D drug coverage, either a stand-alone prescription drug plan (PDP) as a supplement to traditional Medicare, or a Medicare Advantage prescription drug plan (MA-PD), which provides all Medicare-covered benefits including drugs. Part D plans vary in numerous ways that can have a significant effect on an enrollee's out-of-pocket spending, including premiums, deductibles, cost sharing, tier placement, the list of covered drugs, and preferred pharmacies. This issue brief provides an overview of the 2018 Part D PDP landscape, the largest segment of the Part D marketplace, with 20.4 million enrollees in 2017 (excluding enrollees in employer-only PDPs, for whom plan premium and benefits data are unavailable). For detail on the data and methods, see the Methods section.
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
Extent:
1 online resource (1 PDF file (21 pages))
Illustrations:
Illustrations
NLM Unique ID:
101717210 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101717210